Showing results (61-70 of 335) with videos related to
Sort By:
Pageof 34
Acta Haematologica|March 30, 2017
A Revised Fibrinogen Cutoff Value in the Chinese Disseminated Intravascular Coagulation Scoring System May Provide a Better Prognostic Value for Hematological MalignanciesQing Wei, Ting Niu, Mengyao Wang, et al.Frontiers in Pharmacology|February 26, 2025
The clinical characteristics and implications of acute kidney injury during induction therapy for acute promyelocytic leukemiaKai Shen, Chenlu Yang, Jie Huang, et al.Microorganisms|December 31, 2025
Isavuconazole for the Treatment of Invasive Fungal Disease in Hematology Patients: A Real-World Retrospective Study on Efficacy and SafetyPazilaiti Tuohuti, Yuhui Chen, Ailin Zhao, et al.Targeted Oncology|February 10, 2026
Evidence for the Monitoring of Minimal Residual Disease Dynamics to Guide Clinical Practice in Patients with Multiple MyelomaXinai Gan, Linfeng Li, Li Zhang, et al.The Oncologist|April 12, 2025
Epidemiology characteristics and clinical outcomes of composite Hodgkin lymphoma and diffuse large B-cell lymphoma using machine learningAilin Zhao, Xu Sun, Weishi Cheng, et al.Frontiers in Oncology|September 16, 2022
An emerging prognosis prediction model for multiple myeloma: Hypoxia-immune related microenvironmental gene signatureZhengyu Yu, Bingquan Qiu, Linfeng Li, et al.Oncology Letters|December 2, 2015
Acute promyelocytic leukemia harbouring rare FLT3-TKD and WT1 mutations: A case reportTing-Ting Liu, K E Zeng, Lin Wang, et al.Frontiers in Immunology|March 17, 2025
A comprehensive prognostic and immune analysis of LAPTM4B in pan-cancer and Philadelphia chromosome-positive acute lymphoblastic leukemiaHui Zhou, Yuyao Yi, Wei He, et al.Signal Transduction and Targeted Therapy|January 11, 2024
Fc receptor-like 5 (FCRL5)-directed CAR-T cells exhibit antitumor activity against multiple myelomaZhengyu Yu, Hexian Li, Qizhong Lu, et al.Small Methods|December 1, 2023
Macrophage-Biomimetic Nanoplatform-Based Therapy for Inflammation-Associated DiseasesYing Qu, Bingyang Chu, Jianan Li, et al.Pageof 34